The xanthine derivative 16 decreases the quantity of tumor-associated CD11b+Gr-1+ cells within melanoma cells as well as the levels of immune regulatory mediators like interleukin-10 (IL-10) and monocyte chemoattractant protein 1 (MCP-1). Here, CCL2 is linked to melanoma.